| dfped-package | Extrapolation and Bridging of Adult Information in Early Phase Dose-Finding Paediatrics Studies |
| albAge | Concentration of albumin according to age. |
| alpha1AGage | Concentration of alpha1-acid glycoprotein according to age. |
| Cladu | Clearance of the unbound fraction of a specific molecule for the adult population. |
| Clch.Allo | Paediatric clearance according to the allometry adjustment (AA) for a specific age. |
| Clch.Linear | Paediatric clearance according to the linear adjustment (LA) for a specific age. |
| Clch.Mat | Paediatric clearance according to the maturation adjustment (MA) for a specific age. |
| Clchu | Clearance of the unbound fraction of a specific molecule for the paediatric population. |
| concAd | Concentration of a specific molecule in plasma for the adult population. |
| concCh | Concentration of a specific molecule in plasma for the paediatric population. |
| crmAtj | A simulation of a single dose-finding trials in paediatrics. |
| dfped | Extrapolation and Bridging of Adult Information in Early Phase Dose-Finding Paediatrics Studies |
| doseChoice | Choice of the next given dose level. |
| doseRange | Dose-range for the paediatric population according to adult clearance, adult doses and paediatric clearance. |
| Fch | Paediatric bioavailability according to age. |
| fitDataj | Function for the Watanabe-Akaike information criteria (WAIC) |
| fuCh | Unbound fraction of the molecule in the plasma for children. |
| KCYP1A2 | Fraction of adult CYP1A2 abundance according to age. |
| KCYP2B6 | Fraction of adult CYP2B6 abundance according to age. |
| KCYP2C18_19 | Fraction of adult CYP2C18/CYP2C19 abundance according to age. |
| KCYP2C8 | Fraction of adult CYP2C8 abundance according to age. |
| KCYP2C9 | Fraction of adult CYP2C9 abundance according to age. |
| KCYP2D6 | Fraction of adult CYP2D6 abundance according to age. |
| KCYP2E1 | Fraction of adult CYP2E1 abundance according to age. |
| KCYP3A | Fraction of adult CYP3A abundance according to age. |
| KCYP3A4_5 | Fraction of adult CYP3A4/CYP3A5 abundance according to age. |
| kickoffControl | Control for presence of at least toxicities and efficacies for the good run of bCRM model. |
| metaPhase | Meta-analysis function of dose-finding studies proposed by Zohar et al, (2011). |
| plotEstimates | Build a working model. |
| priorChoice | Decision function for the choice of variance (sigmaHI or sigmaLI) in the adaptive prior variance calibration. |
| saveSimu | Simulate one or "n" dose-finding trials in paediatrics. |
| sigmaEss | The variance of the effective sample size (ESS). |
| sigmaHI | Compute the informative prior variance for the adaptive prior. |
| sigmaLI | Compute the least informative prior variance for the adaptive prior. |
| simu | A simulation of a single dose-finding trials in paediatrics. |
| simulation | Simulate one or "n" dose-finding trials in paediatrics. |
| skeleton | Build a working model. |
| waic | Function for the Watanabe-Akaike information criteria (WAIC) |
| weightCYPsum | Proportion of the molecule metabolised by the CYPs for a child according to age. |